ASTM E2526 Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
Данный раздел/документ содержится в продуктах:
- Техэксперт: Машиностроительный комплекс
- Картотека зарубежных и международных стандартов
- ASTM F2451 Standard Guide for in vivo Assessment of Implantable Devices Intended to Repair or Regenerate Articular Cartilage
- ASTM G125 Standard Test Method for Measuring Liquid and Solid Material Fire Limits in Gaseous Oxidants
- ASTM D618 Standard Practice for Conditioning Plastics for Testing
- ASTM D6712 Standard Specification for Ultra-High-Molecular-Weight Polyethylene (UHMW-PE) Solid Plastic Shapes
- ASTM D4020 Standard Specification for Ultra-High-Molecular-Weight Polyethylene Molding and Extrusion Materials
- ASTM F2695 Standard Specification for Ultra-High Molecular Weight Polyethylene Powder Blended With Alpha-Tocopherol (Vitamin E) and Fabricated Forms for Surgical Implant Applications
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2212 Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs)
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2695 Standard Specification for Ultra-High Molecular Weight Polyethylene Powder Blended With Alpha-Tocopherol (Vitamin E) and Fabricated Forms for Surgical Implant Applications
- ASTM D4020 Standard Specification for Ultra-High-Molecular-Weight Polyethylene Molding and Extrusion Materials
- ASTM D6712 Standard Specification for Ultra-High-Molecular-Weight Polyethylene (UHMW-PE) Solid Plastic Shapes
- ASTM D618 Standard Practice for Conditioning Plastics for Testing
- 13
- ASTM G125 Standard Test Method for Measuring Liquid and Solid Material Fire Limits in Gaseous Oxidants
- ASTM D618 Standard Practice for Conditioning Plastics for Testing
- ASTM D6712 Standard Specification for Ultra-High-Molecular-Weight Polyethylene (UHMW-PE) Solid Plastic Shapes
- ASTM D4020 Standard Specification for Ultra-High-Molecular-Weight Polyethylene Molding and Extrusion Materials
- ASTM F2695 Standard Specification for Ultra-High Molecular Weight Polyethylene Powder Blended With Alpha-Tocopherol (Vitamin E) and Fabricated Forms for Surgical Implant Applications
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2212 Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs)
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2695 Standard Specification for Ultra-High Molecular Weight Polyethylene Powder Blended With Alpha-Tocopherol (Vitamin E) and Fabricated Forms for Surgical Implant Applications
- ASTM D4020 Standard Specification for Ultra-High-Molecular-Weight Polyethylene Molding and Extrusion Materials
- ASTM D6712 Standard Specification for Ultra-High-Molecular-Weight Polyethylene (UHMW-PE) Solid Plastic Shapes
- ASTM D618 Standard Practice for Conditioning Plastics for Testing
- 13.220
- ASTM G125 Standard Test Method for Measuring Liquid and Solid Material Fire Limits in Gaseous Oxidants
- ASTM D618 Standard Practice for Conditioning Plastics for Testing
- ASTM D6712 Standard Specification for Ultra-High-Molecular-Weight Polyethylene (UHMW-PE) Solid Plastic Shapes
- ASTM D4020 Standard Specification for Ultra-High-Molecular-Weight Polyethylene Molding and Extrusion Materials
- ASTM F2695 Standard Specification for Ultra-High Molecular Weight Polyethylene Powder Blended With Alpha-Tocopherol (Vitamin E) and Fabricated Forms for Surgical Implant Applications
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2212 Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs)
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2695 Standard Specification for Ultra-High Molecular Weight Polyethylene Powder Blended With Alpha-Tocopherol (Vitamin E) and Fabricated Forms for Surgical Implant Applications
- ASTM D4020 Standard Specification for Ultra-High-Molecular-Weight Polyethylene Molding and Extrusion Materials
- ASTM D6712 Standard Specification for Ultra-High-Molecular-Weight Polyethylene (UHMW-PE) Solid Plastic Shapes
- ASTM D618 Standard Practice for Conditioning Plastics for Testing
- ASTM G125 Standard Test Method for Measuring Liquid and Solid Material Fire Limits in Gaseous Oxidants
- ASTM G125 Standard Test Method for Measuring Liquid and Solid Material Fire Limits in Gaseous Oxidants
- ASTM D6712 Standard Specification for Ultra-High-Molecular-Weight Polyethylene (UHMW-PE) Solid Plastic Shapes
- ASTM D4020 Standard Specification for Ultra-High-Molecular-Weight Polyethylene Molding and Extrusion Materials
- ASTM F2695 Standard Specification for Ultra-High Molecular Weight Polyethylene Powder Blended With Alpha-Tocopherol (Vitamin E) and Fabricated Forms for Surgical Implant Applications
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2212 Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs)
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2695 Standard Specification for Ultra-High Molecular Weight Polyethylene Powder Blended With Alpha-Tocopherol (Vitamin E) and Fabricated Forms for Surgical Implant Applications
- ASTM D4020 Standard Specification for Ultra-High-Molecular-Weight Polyethylene Molding and Extrusion Materials
- ASTM D4020 Standard Specification for Ultra-High-Molecular-Weight Polyethylene Molding and Extrusion Materials
- ASTM F2695 Standard Specification for Ultra-High Molecular Weight Polyethylene Powder Blended With Alpha-Tocopherol (Vitamin E) and Fabricated Forms for Surgical Implant Applications
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2212 Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs)
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2695 Standard Specification for Ultra-High Molecular Weight Polyethylene Powder Blended With Alpha-Tocopherol (Vitamin E) and Fabricated Forms for Surgical Implant Applications
- ASTM F2695 Standard Specification for Ultra-High Molecular Weight Polyethylene Powder Blended With Alpha-Tocopherol (Vitamin E) and Fabricated Forms for Surgical Implant Applications
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2212 Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs)
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F763 Standard Practice for Short-Term Screening of Implant Materials
- ASTM F2212 Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs)
- ASTM F2212 Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs)
- ASTM F981 Standard Practice for Assessment of Compatibility of Biomaterials for Surgical Implants with Respect to Effect of Materials on Muscle and Bone
- ASTM F2721 Standard Guide for Pre-clinical in vivo Evaluation in Critical Size Segmental Bone Defects
- ASTM F895 Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
- Картотека зарубежных и международных стандартов
ASTM International
Standard Test Method for Evaluation of Cytotoxicity of Nanoparticulate Materials in Porcine Kidney Cells and Human Hepatocarcinoma Cells
N E2526
Annotation
This test method provides a methodology to assess the cytotoxicity of suspensions of nanoparticulate materials in porcine proximal tubule cells (LLC-PK1) and human hepatocarcinoma cells (Hep G2) which represents potential target organs following systemic administration
This test method is part of the in vitro preclinical characterization cascade.
This test method consists of a protocol utilizing two methods for estimation of cytotoxicity, 3-(4,5- Dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) reduction and lactate dehydrogenase (LDH) release.
The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
Автоматический перевод:
Стандартный метод испытаний для оценки цитотоксичности материалов Nanoparticulate в свиных почечных клетках и человеческих клетках Hepatocarcinoma



